During the past decade, KMH Cardiology & Diagnostics Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "KMH Cardiology & Diagnostics Centre" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "KMH Cardiology & Diagnostics Centre" are "Heart Failure" (2 trials), "Atherosclerosis" (1 trials) and "Vascular Disease" (1 trials). Many other conditions were trialed in "KMH Cardiology & Diagnostics Centre" in a lesser frequency.

Most popular intervention types in "KMH Cardiology & Diagnostics Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "KMH Cardiology & Diagnostics Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "KMH Cardiology & Diagnostics Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in KMH Cardiology & Diagnostics Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in KMH Cardiology & Diagnostics Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".